Insider · CIK 0001368298
Surendra K Ajjarapu
Files at MEDS (Wellgistics Health, Inc.). First filing -, latest -.
In brief
Surendra K Ajjarapu files SEC Form 4 as director at MEDS (Wellgistics Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Surendra K Ajjarapu has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | MEDS Wellgistics Health, Inc. | XIn-the-money exercise Common Stock | +100,000 | $0.01 | $500 | 257,645 | Jun 25, 2026 |
| Mar 31, 2026 | MEDS Wellgistics Health, Inc. | AGrant or award Common Stock | +5,000,000 | $0.20 | $1.0M | 7,882,247 | Jun 25, 2026 |
| Jun 22, 2026 | MEDS Wellgistics Health, Inc. | XIn-the-money exercise Warrantderivative | +100,000 | $0.00 | $0 | 0 | Jun 25, 2026 |
| Mar 31, 2026 | MEDS Wellgistics Health, Inc. | AGrant or award Warrantderivative | +5,000,000 | $0.00 | $500 | 5,000,000 | Jun 25, 2026 |
| Mar 31, 2026 | MEDS Wellgistics Health, Inc. | AGrant or award Common Stock | +5,000,000 | $0.20 | $1.0M | 7,882,247 | Apr 23, 2026 |
| Mar 31, 2026 | MEDS Wellgistics Health, Inc. | AGrant or award Warrantderivative | +5,000,000 | $0.01 | $50k | 5,000,000 | Apr 23, 2026 |
| Mar 21, 2025 | MEDS Wellgistics Health, Inc. | AGrant or award Common Stock, Par Value $0.0001 | +2,882,247 | $0.00 | $0 | 1,822,247 | Mar 25, 2025 |
| Mar 21, 2025 | MEDS Wellgistics Health, Inc. | AGrant or award Common Stock, Par Value $0.0001indirect: By the Sandhya Ajjarapu Revocable Trust 2007 | +600,000 | $0.00 | $0 | 4,463,200 | Mar 25, 2025 |
| Mar 21, 2025 | MEDS Wellgistics Health, Inc. | AGrant or award Common Stock, Par Value $0.0001indirect: By Sansur Associates LLC | +600,000 | $0.00 | $0 | 3,100,000 | Mar 25, 2025 |
Questions about Surendra K Ajjarapu
Answered from the filings on this page, as of the latest one.
Is Surendra K Ajjarapu buying or selling?
Surendra K Ajjarapu has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Surendra K Ajjarapu's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Surendra K Ajjarapu has 0.
Where does Surendra K Ajjarapu file Form 4?
Surendra K Ajjarapu has filed Form 4 at MEDS (Wellgistics Health, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.